Cargando…
High-throughput fetal fraction amplification increases analytical performance of noninvasive prenatal screening
PURPOSE: The percentage of a maternal cell-free DNA (cfDNA) sample that is fetal-derived (the fetal fraction; FF) is a key driver of the sensitivity and specificity of noninvasive prenatal screening (NIPS). On certain NIPS platforms, >20% of women with high body mass index (and >5% overall) re...
Autores principales: | Welker, Noah C., Lee, Albert K., Kjolby, Rachel A. S., Wan, Helen Y., Theilmann, Mark R., Jeon, Diana, Goldberg, James D., Haas, Kevin R., Muzzey, Dale, Chu, Clement S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935715/ https://www.ncbi.nlm.nih.gov/pubmed/33190143 http://dx.doi.org/10.1038/s41436-020-01009-5 |
Ejemplares similares
-
Response to “Noninvasive prenatal screening at low fetal fraction: comparing whole‐genome sequencing and single‐nucleotide polymorphism methods”
por: Muzzey, Dale, et al.
Publicado: (2017) -
The impact of HBB‐related hemoglobinopathies carrier status on fetal fraction in noninvasive prenatal screening
por: Putra, Manesha, et al.
Publicado: (2022) -
Noninvasive prenatal screening for patients with high body mass index: Evaluating the impact of a customized whole genome sequencing workflow on sensitivity and residual risk
por: Muzzey, Dale, et al.
Publicado: (2019) -
Bioinformatics Approaches for Fetal DNA Fraction Estimation in Noninvasive Prenatal Testing
por: Peng, Xianlu Laura, et al.
Publicado: (2017) -
Factors Affecting the Fetal Fraction in Noninvasive Prenatal Screening: A Review
por: Deng, Cechuan, et al.
Publicado: (2022)